性别差异对胰腺癌的生存没有影响
1Department of Medical Oncology, Institute of Oncology, University of Istanbul, Capa, 34390 Istanbul, Turkey.
Indian journal of surgical oncology
|February 23, 2026
概括
这项研究发现,男性和女性胰腺癌存活率没有显著差异. 性似乎不会影响胰腺癌患者在所有疾病阶段的整体存活率.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 性在癌症中的临床意义
背景情况:
- 性对胰腺癌结果的临床影响仍然存在争议.
- 之前的研究对胰腺癌的性别差异产生了相互矛盾的结果.
研究的目的:
- 为了研究胰腺癌患者性别的临床意义.
- 为了确定性别是否影响胰腺癌的生存率和临床变量.
主要方法:
- 对334名胰腺癌患者的回顾性分析.
- 评估不同疾病阶段 (局部,局部晚期,转移性) 的性别分布.
- 血清乳酸脱酶 (LDH) 水平和按性别的整体生存率的评估.
主要成果:
- 疾病不同阶段的性别分布没有显著差异 (p=0.9).
- 患有转移性胰腺癌的女性的血清LDH水平比男性高 (p=0.009).
- 总体生存率在所有疾病阶段 (转移性p=0.2,局部晚期p=0.6,局部p=0.09) 的性别之间是相似的.
结论:
- 没有发现性对胰腺癌患者的整体存活率有显著影响.
- 虽然在转移性疾病的妇女中观察到较高的LDH水平,但这并没有转化为生存差异.
- 这些发现表明,性别不是胰腺癌生存的决定因素.
相关概念视频
Cancer Survival Analysis
793
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
793
Comparing the Survival Analysis of Two or More Groups
652
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
652


